CD44 and breast neoplasm: Breast cancer stem cells have been isolated from human breast tumors or breast cancer-derived pleural effusions using flow cytometry to find subpopulations of cells with a specific pattern of cell surface markers (CD44+, CD24−/low, ESA+ (epithelial specific antigen)) but lacking expression of specific lineage markers (Lin−) [10].